Drug Trial Radar · NCT06359535
An Economic Study of HSK21542 Injection for Prevention of Postoperative Nausea and Vomiting
Last checked: Nov 20, 2026Latest source record: Apr 11, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
200
Planned (sponsor's estimate)
Start
Feb 23, 2024
Primary completion
Nov 6, 2024
Study completion Nov 6, 2024
Sponsor
- Lead sponsor
- Mengchang YangAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 11, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study analyzed the efficacy and safety results of HSK21542 injection for the prevention of postoperative nausea and vomiting in a multicentre, randomized, double-blind, placebo-controlled dose-exploration study, as well as the real-world clinical routine use of troisisone and other (not limited to other setron drugs) for the prevention of postoperative nausea and vomiting and related adverse reaction treatment data. It was transformed into an effect indicator, and the possible costs involved in the study were analyzed, reasonable price parameters of HSK21542 injection were set, and the economic value of HSK21542 was explored.
Conditions
- Nausea and Vomiting, Postoperative
Interventions
HSK21542Drug
This study is an economic study and does not interfere with patients' medical treatment.
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total direct medical costs, direct non-medical costs, indirect costsTime frame: 24 hours after the end of surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.